SkinSync® Technology

Dissolvable Nanofibrous Patches

HOW IT'S MADE

From polymer to nanofibre.

Our Nanofibrous Patches are made from carefully selected biodegradable polymers. The polymers are mixed with the drug and then transformed into very small nano fibres using an innovative technology called electro-spinning. The nanofibres are produced by applying electrostatic field between the polymeric solution deposited on a wire. The electrostatic force “spins” the fibers which are then collected in the form of a non-woven mat on a substrate. The structure of the mat is very open, structurally similar to Cotton Candy. The machine produces rolls of this nano-fibrous mat that are then sent to our manufacturing partner who transforms them into patches.

HOW IT WORKS

Rapid dissolution, controlled delivery.

When the nanofibrous mat comes in contact with moisture, it rapidly dissolves. This rapid dissolution in the presence of a small amount of moisture is due to the combination of high surface area provided by the nanofibres and the nature of the polymer. As it dissolves, the patch transfers the drug to the skin in a controlled fashion delivering the expected therapeutic effect. In contrast to most commercial patches, no residue remains on the patch and it can be safely disposed of.

01

Electrospinning

Polymer + drug spun into ultrafine nanofibres via electrostatic field.

02

Moisture Contact

Nanofibrous mat rapidly dissolves on contact with moistened skin.

03

Controlled Release

Active ingredient permeates the skin over a 12h–72h application window.

ADVANTAGES

Why SkinSync® outperforms conventional patches.

The encapsulation of the drug in the nanofibres preserves it in an amorphous state which enhances its solubility and bioavailability.

  • The rapid dissolution of the nanofibres leads to a rapid release of the drug to the skin.

  • The permeation of the drug through the skin is enhanced without using permeation enhancers.

  • This leads to a significantly higher efficiency compared to commercial patches. This means that we can use less drug for the same therapeutic results, ultimately leading to the production of cheaper and smaller patches.

  • The electro-spinning process is scalable to large industrial scale.

Interested in licensing or co-development?

Connect with the EncapSolutions team to discuss partnership, licensing, or collaboration.